
Emanuel Della-Torre, MD, PhD, discusses the largest randomized controlled trial in IgG4-RD establishing proof of concept for B-cell inhibition.

Assistant Professor of Rheumatology at Vita-Salute San Raffaele University and a Senior Consultant at San Raffaele Hospital's Unit of Immunology, Rheumatology, Allergy, and Rare Disease (UnIRAR)